Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder - Wikidata - wikimedia - TriplyDB

Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder

Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder

http://www.wikidata.org/entity/Q36610063

about

Alzheimer's Disease associated with Psychiatric Comorbidities Dysregulation of leukocyte gene expression in women with medication-refractory depression versus healthy non-depressed controls.Personality traits in bipolar disorder and influence on outcome Elevated concentrations of neurofilament light chain in the cerebrospinal fluid of bipolar disorder patients.Heteromers of amyloid precursor protein in cerebrospinal fluid.Cognitive functioning in clinically stable patients with bipolar disorder I and II Cognitive performance and cerebrospinal fluid biomarkers of neurodegeneration: a study of patients with bipolar disorder and healthy controls.Cortical thickness, volume and surface area in patients with bipolar disorder types I and II Genome-wide association study identifies SESTD1 as a novel risk gene for lithium-responsive bipolar disorder Iron dysregulates APP processing accompanying with sAPPα cellular retention and β-secretase inhibition in rat cortical neurons.Classification of cognitive performance in bipolar disorder.Areas of controversy in neuroprogression in bipolar disorder.Restoring Soluble Amyloid Precursor Protein α Functions as a Potential Treatment for Alzheimer's Disease.Effects of lithium and valproic acid on BDNF protein and gene expression in an in vitro human neuron-like model of degeneration.Genome-wide association study of 40,000 individuals identifies two novel loci associated with bipolar disorder.Cerebrospinal fluid microglia and neurodegenerative markers in twins concordant and discordant for psychotic disorders.Lithium-Associated Hypercalcemia: Pathophysiology, Prevalence, Management.Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.Bipolar Disorder and Frontotemporal Dementia: An Intriguing Association.Cortical brain structure and sexual orientation in adult females with bipolar disorder or attention deficit hyperactivity disorder

P2860

Q26796602-73322D70-63F1-4551-8CB3-928616B32D2C Q33588628-5F75E786-D108-4F6B-9EF0-A26A70F3D24E Q33634599-50B10B69-E9A3-47AB-BAEC-D53D3D3D0781 Q34068878-CEC700D2-DACD-4D47-88D7-A6CAFEFD3356 Q34981218-F7570F0A-241E-49BE-A3F1-C926D2A17973 Q35007228-89C7069E-329F-4B57-B9A2-CB68D9F50A13 Q35587114-F8DB6566-7774-4773-8CF3-8B5BBFDA24C0 Q37026306-DB34EF8A-BE2B-4EEB-8EF5-2234549AD2FD Q37199024-346377A4-60AF-4F93-A96A-41614C539BB0 Q38610668-4ACCFE1C-1737-4347-BA9C-3E4EC010D4D2 Q38633591-1DBF8DA7-56B6-48E9-BCB9-270745A4F274 Q38812942-77935DF5-A7CE-4745-9A88-53B941B94891 Q38929253-3A1997CA-A29E-4809-9C4B-C368D7A82921 Q39008341-5AFD2B4D-DB76-41E4-9A60-CBCB51A4D231 Q39732399-45DC9870-84EA-4AE5-902F-8937912CC51A Q40401151-CF307440-B6B8-4927-854D-F051140E9357 Q47279229-4DB8079F-2A13-494D-BE58-C3EF4F736FD3 Q50541738-F2CDF864-5000-4ED6-AF8C-8AE45013F7C3 Q50541776-08141EFC-64B1-4FF9-AC65-9DD29EC22906 Q54018156-DA5E40A4-34FC-4C1B-A356-880C4B0F1647 Q57177788-F0CE23BF-F729-4069-9F48-227C6066948D

P2860

Altered concentrations of amyloid precursor protein metabolites in the cerebrospinal fluid of patients with bipolar disorder

http://www.wikidata.org/entity/Q36610063

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Altered concentrations of amyl ...... patients with bipolar disorder

@ast

Altered concentrations of amyl ...... patients with bipolar disorder

@en

type

label

Altered concentrations of amyl ...... patients with bipolar disorder

@ast

Altered concentrations of amyl ...... patients with bipolar disorder

@en

prefLabel

Altered concentrations of amyl ...... patients with bipolar disorder

@ast

Altered concentrations of amyl ...... patients with bipolar disorder

@en

P1433

Q36610063-2784375B-2308-4DB8-9544-ADCFEAE63D9C

P1476

Q36610063-5BEC17B6-175B-40F3-98B4-2CD54D840D63

P2093

Q36610063-59059A7D-33C3-453D-B134-5600EF484B22

Q36610063-61C584C5-ACD2-4F64-BD44-B59188882B9C

Q36610063-9FE299FC-255E-4743-8C3C-0881A1AC0980

P2860

Q36610063-040FDBFE-C811-4268-A8C2-F12D89348F94

Q36610063-074A53DD-D73A-4835-8191-BC9A653D37A5

Q36610063-08C9EE8C-7B4F-4C51-A1ED-7CAB1C0F0AA6

Q36610063-0A72E92B-3B4B-4E24-8A56-4B40BD18FDE6

Q36610063-0B78054C-FF66-4691-8298-E444BD815E70

Q36610063-0D72ADBB-CF3E-45B9-975F-F6A8C470A413

Q36610063-17756ADB-CDEB-4681-945F-C12B791BF98B

Q36610063-1E1790F6-6C82-45B0-94E2-9E1278047AB1

Q36610063-39358617-6514-480E-B57A-E1AD4FBB8D37

Q36610063-3E935422-1EBD-4096-95CA-C2AD4313D71E

P2888

Q36610063-81564FCC-A1F0-46FA-99D7-BFAB7E441276

P304

Q36610063-72EB7FDD-4C9F-443C-9DD4-B906773142A0

P31

Q36610063-0F41CF4F-BEBA-4E81-8E9A-22AE25340762

P356

Q36610063-42C27A5B-9C3D-4CC9-9CD6-A2D50D4E469B

P407

Q36610063-42771F71-669E-418D-B6B3-54957640ACE8

P433

Q36610063-4E6CB1EC-DC92-4973-97FD-BCCC96C4E2B8

P478

Q36610063-07EB298D-16A2-418F-AF6D-3B6F32CFB483

P50

Q36610063-0436C73D-9448-4471-9D00-B43E7ED18E52

Q36610063-4B19ED19-A644-43D4-8068-CC80C98E7584

Q36610063-72CE6A94-9A28-408D-8447-0D1FE281B9F2

P577

Q36610063-64FE2412-8B8E-4266-B8BC-5DCB02CEC2B1

P5875

Q36610063-AE03DBC1-054A-44DC-A4D5-7EF81AC6FA20

P698

Q36610063-F4A6AFA5-BB22-466D-B8C9-2DF62F9E5E69

P921

Q36610063-12786A42-7294-4624-BF37-687DEA6F530A

Q36610063-81EE0D34-64F4-4AD8-AFF9-B8ADFE51140D

P932

Q36610063-559AF911-A421-4B78-8921-C54351A936A7

P356

P1433

Neuropsychopharmacology

P1476

Altered concentrations of amyl ...... patients with bipolar disorder

@en

P2093

Anette G M Johansson

http://www.w3.org/2001/XMLSchema#string

Carl Johan Ekman

http://www.w3.org/2001/XMLSchema#string

Joel Jakobsson

http://www.w3.org/2001/XMLSchema#string

P2860

Meta-analysis, Database, and Meta-regression of 98 Structural Imaging Studies in Bipolar Disorder

Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio

APP processing in Alzheimer's disease

Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory

GSK-3alpha regulates production of Alzheimer's disease amyloid-beta peptides

Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II

DISC1-binding proteins in neural development, signalling and schizophrenia

Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: proposal of a specific, anabolic pathway and putative biomarker

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

P2888

P304

664-672

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NPP.2012.231

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P50

Henrik Zetterberg

P577

2012-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233849263

http://www.w3.org/2001/XMLSchema#string

P698

23212456

http://www.w3.org/2001/XMLSchema#string

P921

bipolar disorder

cerebrospinal fluid

P932

3572463

http://www.w3.org/2001/XMLSchema#string